Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» emtricitabine
emtricitabine
Seven $1 billion-plus drugs seen reaching market in 2016
Yahoo/Reuters
Thu, 02/4/16 - 09:29 am
Intercept Pharmaceuticals
Gilead Sciences
Roche
AbbVie
Merck
obeticholic acid
emtricitabine
Gilead Sciences: New HIV Drug Put To Question
Bidness, ETC
Wed, 11/11/15 - 09:09 pm
Gilead Sciences
HIV
Genvoya
elvitegravir
cobicistat
emtricitabine
TAF
4 Key FDA Decisions Expected in November and December
24/7 Wall St
Sun, 11/1/15 - 11:18 am
FDA
Androxal
Repros Therapeutics
elvitegravir
cobicistat
emtricitabine
tenofovir alafenamide
OPuS-2
Biocryst
Synergy Pharmaceuticals
plecanatide
Gilead's low-dose, high-impact HIV drug heads to the FDA
Bizjournals.com
Wed, 04/8/15 - 10:17 am
Gilead Sciences
HIV
FDA
tenofovir
emtricitabine
Gilead and Janssen expand partnership in HIV
Seeking Alpha
Mon, 12/29/14 - 10:55 am
Gilead Sciences
Janssen
HIV
tenofovir
rilpivirine
emtricitabine